What's hot
View all perspectives
What's Hot
Rheumatoid Arthritis Comorbidities
Dr. Jonathan Kay reviews rheumatoid arthritis studies presented on day at EULAR 2022. Specifically, he discusses abstracts OP0132, OP0135 and OP0138.
Watch video →
Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders
Dr. Peter Nash discusses abstract OP0023 from EULAR 2022.
Watch video →
DMARDS, Prednisone, Pregnancy, OH MY!
Dr. Kathryn Dao discusses abstracts POS1405, POS0696 and OP0130 presented at the EULAR 2022 meeting. Watch more videos from EULAR 2022 here: https://rheumnow.com/videos.
Watch video →
Breathing New Insight into RA Interstitial Lung Disease
Dr. Jonathan Kay reviews EULAR 2022 abstracts OP0132, OP0306, and OP0307.
Watch video →
EULAR 2022 - Day 4 Faculty Panel Recap
Dr. David Liew and Dr. Jack Cush discuss day 4 of EULAR 2022. LB0001, LB0002, LB0004, and LB0006.
Watch video →
Getting to the Heart of JAK Inhibitors
Dr. Jonathan Kay reviews rheumatoid arthritis sessions and abstracts from day 3 at EULAR 2022. Abstracts reviewed: OP0266; OP0258; and OP0269.
Watch video →
EULAR 2022 - Day 3 Faculty Panel Recap
Drs. Jack Cush, Janet Pope, Aurelie Najm and Yuz Yusof discuss highlights from Day 3 of EULAR 2022.
Watch video →
Deucravacitinib at EULAR 2022
Dr. Peter Nash provides and update on the TYK2 inhibitor, Deucravacitinib with reports on: - Safety of Deucravacitinib https://bit.ly/3NtZQxe - Deucravacitinib in SLE https://bit.ly/3Mh5nG0
Watch video →
Aurelie Najm AurelieRheumo
3 years 6 months ago
☄️ Biomarkers substudies of COSMOS & DISCOVER-1 RCT GUS in PsA:
TNFi-IR pts have a different plasma signature w/ higher BL IL-22 & TNF
*Association between BL IL-22 levels & W24 PASI75
and trend for BL IL-22 levels & W24 ACR20
#EULAR2022 @RheumNow POS0074 @StefanSiebert1 https://t.co/Midtug4NJO
TheDaoIndex KDAO2011
3 years 6 months ago
Dr. K Hyrich who/when to vaccinate. #EULAR2022 @rheumnow https://t.co/40y9ngJnbW
TheDaoIndex KDAO2011
3 years 6 months ago
#Vaccine disparities globally #EULAR2022 @rheumnow https://t.co/w12ok1Y1b5
Eric Dein ericdeinmd
3 years 6 months ago
Kimme Hydrich: There is no increased of "exceedingly rare" vaccination adverse effects in rheumatic patients
💉APLS is NOT a risk factor for thrombotic AEs with vaccination
#EULAR2022 @Rheumnow @rheum_covid
Richard Conway RichardPAConway
3 years 6 months ago
HAS-GCA study @alwinuk @profbdasgupta Southend pretest probability score and Halo score useful in diagnosis and prognosis in GCA. Halo score may be useful for monitoring. @RheumNow #EULAR2022 POS0818 https://t.co/sxYjnQQFA8
Aurelie Najm AurelieRheumo
3 years 6 months ago
Do you vaccine pts w/ RMDs for shingles?
If so, when and who and with what?
@khyrich highlights differences in recommendations and contra-indications across countries
#EULAR2022 @RheumNow https://t.co/c0uvOPopF4
TheDaoIndex KDAO2011
3 years 6 months ago
“One of the benefits of #vaccinations people don’t talk about is the relief they feel after vaccination."
- Dr E Hyrich #EULAR2022 @rheumnow
Dr. John Cush RheumNow
3 years 6 months ago
RheumNow’s coverage of the #EULAR2022 Annual meeting is sponsored in part by Bristol-Myers Squibb. All content is chosen by RheumNow & its Faculty.
Aurelie Najm AurelieRheumo
3 years 6 months ago
💫Trajectory analysis in SpA💫
Data on 1,125 patients
Prediction of spinal radiographic progression
⭐️FAST associated w/ onset at older age & 👁involvement
⭐️SLOW progression associated w/ female gender & peripheral involvement.
#EULAR2022 @RheumNow OP0151 https://t.co/E80qCLEtBv
Richard Conway RichardPAConway
3 years 6 months ago
Preito-Pena at al. Tocilizumab in LVV-GCA and TAK. Similar responses in both, with 75% showing complete clinical response but only 20% complete imaging response at month 12. Clinical implications of these persistent imaging findings need clarification @RheumNow #EULAR2022 POS0804 https://t.co/sNbRzIkwnt
Eric Dein ericdeinmd
3 years 6 months ago
#EULAR2022
"The mRNA vaccines are simple to make." - Saul Faust
The key step is encapsulation in lipid to allow for take up by cell.
💉💉💉
@RheumNow https://t.co/T2ZxF6bLV5
Richard Conway RichardPAConway
3 years 6 months ago
Comorbidity in AS from @rheum_cat , Karmacharya et al. Clustering of comorbidities. Depression and hypertension clusters assoc worse disease activity and function @RheumNow #EULAR2022 OP0154 https://t.co/jGQXayAYs9 https://t.co/SnVDhVYQq5
Richard Conway RichardPAConway
3 years 6 months ago
Flatman et al. Serious infections in babies born to women using TNFi during pregnancy. 2902 babies. Adjusted HR 1.20 (0.54-2.64) for agents with high vs low placental transfer. @RheumNow #EULAR2022 OP0130 https://t.co/oaW7wDPxva
Eric Dein ericdeinmd
3 years 6 months ago
#EULAR2022 OP0134: Active RA increases risk of dementia
Olmsted County, MINN studying RA risk factors for dementia:
⭐️886 pts incident RA, mean age 65. 103 develop dementia
Risk factors: Age, rheum nodules, large jt swelling, depression/anxiety, HTN, CVD events
@Rheumnow https://t.co/bUFkzBovAy
Richard Conway RichardPAConway
3 years 6 months ago
Fonzetti et al. Isolated Ro-52 in pSS. 300 patients. Less inflammatory features but more fibrotic disease - ILD and PBC. @RheumNow #EULAR2022 OP0146 https://t.co/2WIAu8qKiH https://t.co/mspSBNxbx2
Poster Hall